Generation and characterization of a trackable plant-made influenza H5 virus-like particle (VLP) containing enhanced green fluorescent protein (eGFP)
出版年份 2015 全文链接
标题
Generation and characterization of a trackable plant-made influenza H5 virus-like particle (VLP) containing enhanced green fluorescent protein (eGFP)
作者
关键词
-
出版物
FASEB JOURNAL
Volume 29, Issue 9, Pages 3817-3827
出版商
FASEB
发表日期
2015-06-03
DOI
10.1096/fj.15-270421
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens
- (2014) Nathalie Landry et al. CLINICAL IMMUNOLOGY
- Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants
- (2014) François Le Mauff et al. PLANT BIOTECHNOLOGY JOURNAL
- How advances in immunology provide insight into improving vaccine efficacy
- (2014) Mark K. Slifka et al. VACCINE
- Predicting the Loading of Virus-Like Particles with Fluorescent Proteins
- (2013) W. Frederik Rurup et al. BIOMACROMOLECULES
- Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles
- (2013) Armando Stano et al. BIOMATERIALS
- Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development
- (2013) William A Rodríguez-Limas et al. CURRENT OPINION IN BIOTECHNOLOGY
- Understanding the evolutionary relationship of hemagglutinin protein from influenza viruses using phylogenetic and molecular modeling studies
- (2013) Muthusamy Karthikeyan et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Generation of HIV-1 Gag VLPs by transient transfection of HEK 293 suspension cell cultures using an optimized animal-derived component free medium
- (2013) Laura Cervera et al. JOURNAL OF BIOTECHNOLOGY
- Generation of Effector Memory T Cell-Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination
- (2013) A. V. Li et al. Science Translational Medicine
- Virus-based nanocarriers for drug delivery
- (2012) Yujie Ma et al. ADVANCED DRUG DELIVERY REVIEWS
- Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
- (2012) Natasha Kushnir et al. VACCINE
- Colorful Virus-like Particles: Fluorescent Protein Packaging by the Qβ Capsid
- (2011) Jin-Kyu Rhee et al. BIOMACROMOLECULES
- Applications of viral nanoparticles in medicine
- (2011) Ibrahim Yildiz et al. CURRENT OPINION IN BIOTECHNOLOGY
- Influenza virosomes as a vaccine adjuvant and carrier system
- (2011) Christian Moser et al. Expert Review of Vaccines
- Hepatitis E virus enters liver cells through receptor-dependent clathrin-mediated endocytosis
- (2011) N. Kapur et al. JOURNAL OF VIRAL HEPATITIS
- Bio-inspired, bioengineered and biomimetic drug delivery carriers
- (2011) Jin-Wook Yoo et al. NATURE REVIEWS DRUG DISCOVERY
- Influenza virus assembly and budding
- (2011) Jeremy S. Rossman et al. VIROLOGY
- The L1 major capsid protein of HPV16 differentially modulates APC trafficking according to the vaccination or natural infection context
- (2010) Ludivine Herman et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor-ligand interactions
- (2010) Hans J. Kueng et al. FASEB JOURNAL
- Construction and Characterization of Insect Cell-Derived Influenza VLP: Cell Binding, Fusion, and EGFP Incorporation
- (2010) Yi-Shin Pan et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial
- (2010) Feng-Cai Zhu et al. LANCET
- Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus
- (2010) Surender Khurana et al. PLoS One
- Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza
- (2010) Nathalie Landry et al. PLoS One
- Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometry
- (2010) Iwen F Grigsby et al. Retrovirology
- Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different Routes
- (2009) Rafael Cubas et al. JOURNAL OF IMMUNOTHERAPY
- Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine
- (2009) Christian Herzog et al. VACCINE
- An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins
- (2008) Oliver P. Windram et al. ARCHIVES OF VIROLOGY
- Rapid and dynamic subcellular reorganization following mechanical stimulation of Arabidopsis epidermal cells mimics responses to fungal and oomycete attack
- (2008) Adrienne R Hardham et al. BMC PLANT BIOLOGY
- Nanoparticles target distinct dendritic cell populations according to their size
- (2008) Vania Manolova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The M, E, and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-Like Particles
- (2008) Y. L. Siu et al. JOURNAL OF VIROLOGY
- Crystal Structure of Unliganded Influenza B Virus Hemagglutinin
- (2008) Q. Wang et al. JOURNAL OF VIROLOGY
- Influenza virus-like particles produced by transient expression inNicotiana benthamianainduce a protective immune response against a lethal viral challenge in mice
- (2008) Marc-André D’Aoust et al. PLANT BIOTECHNOLOGY JOURNAL
- Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design
- (2007) Juliana Bessa et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started